Deciphera Pharmaceuticals' IPO

Deciphera Pharmaceuticals raised a round of funding on September 28, 2017. Investors include Public.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durab…

Articles about Deciphera Pharmaceuticals' IPO: